Circumvention of Topoisomerase II<i>α</i>Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circumvention of Topoisomerase IIαIntron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells

Published:2024-05-06 Issue:1 Volume:106 Page:33-46
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Wang Xinyi,Carvajal-Moreno Jessika,Zhao Xinyu,Li Junan^ORCID,Hernandez Victor A.,Yalowich Jack C.^ORCID,Elton Terry S.^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Reference69 articles.

1. Therapeutic Antisense Oligonucleotides Are Coming of Age

2. A Deep Neural Network for Predicting and Engineering Alternative Polyadenylation;Bogard;Cell,2019

3. Topoisomerase levels determine chemotherapy responsein vitroandin vivo

4. Metabolic and non-metabolic pathways that control cancer resistance to anthracyclines;Capelôa;Semin Cell Dev Biol,2020

5. New Mechanistic and Functional Insights into DNA Topoisomerases

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP